MaxCyte, Inc. (MXCT) analyst actions
Rating and price-target actions on MXCT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MXCT overview →
6 measured MXCT analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance | Press release | +5.31% | +8.50% | |
| MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance | Press release | +3.95% | — | |
| MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance | Press release | -0.34% | +12.84% | |
| MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance | Press release | +0.86% | +2.72% | |
| MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results | Press release | -0.86% | -11.45% | |
| MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance | Press release | +1.23% | -0.31% |
Keep exploring
More MXCT: earnings → · SEC filings → · MXCT overview →